These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 15224376
21. Thrombophilic Mutations Among Patients with Sickle Cell Disease. Nefissi RB, Ouali F, Massaoud T, Gritli N. Clin Lab; 2017 Nov 01; 63(11):1815-1818. PubMed ID: 29226645 [Abstract] [Full Text] [Related]
22. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis. Eroglu A, Egin Y, Cam R, Akar N. Ann Hematol; 2009 Jan 01; 88(1):73-6. PubMed ID: 18682947 [Abstract] [Full Text] [Related]
23. [Mutation frequencies of the thrombophilic state genes in Uzbekistan]. Sadikova ShE, Karimov KhIa, Muminov ShM, Tulakov RP, Boboev KT. Tsitol Genet; 2008 Jan 01; 42(6):50-4. PubMed ID: 19253755 [Abstract] [Full Text] [Related]
24. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia. Belhaj Nefissi R, Doggui R, Ouali F, Messaoud T, Gritli N. Hemoglobin; 2018 Mar 01; 42(2):96-102. PubMed ID: 30200836 [Abstract] [Full Text] [Related]
25. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N. J Thromb Thrombolysis; 2005 Jun 01; 19(3):189-96. PubMed ID: 16082606 [Abstract] [Full Text] [Related]
26. Mutations in clotting factors and inflammatory bowel disease. Bernstein CN, Sargent M, Vos HL, Rosendaal FR. Am J Gastroenterol; 2007 Feb 01; 102(2):338-43. PubMed ID: 17156138 [Abstract] [Full Text] [Related]
27. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY. Am J Hematol; 2002 Dec 01; 71(4):300-5. PubMed ID: 12447960 [Abstract] [Full Text] [Related]
28. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease. Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N. J Thromb Thrombolysis; 2004 Jun 01; 17(3):199-205. PubMed ID: 15353918 [Abstract] [Full Text] [Related]
29. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis. Ozyurek E, Balta G, Degerliyurt A, Parlak H, Aysun S, Gürgey A. Clin Appl Thromb Hemost; 2007 Apr 01; 13(2):154-60. PubMed ID: 17456624 [Abstract] [Full Text] [Related]
30. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease. Moreira Neto F, Lourenço DM, Noguti MA, Morelli VM, Gil IC, Beltrão AC, Figueiredo MS. Braz J Med Biol Res; 2006 Oct 01; 39(10):1291-5. PubMed ID: 16906320 [Abstract] [Full Text] [Related]
31. Genetic and acquired prothrombotic risk factors and sudden hearing loss. Capaccio P, Ottaviani F, Cuccarini V, Bottero A, Schindler A, Cesana BM, Censuales S, Pignataro L. Laryngoscope; 2007 Mar 01; 117(3):547-51. PubMed ID: 17334320 [Abstract] [Full Text] [Related]
32. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population. Torres JD, Cardona H, Alvarez L, Cardona-Maya W, Castañeda SA, Quintero-Rivera F, Cadavid A, Bedoya G, Tobón L. Am J Hematol; 2006 Dec 01; 81(12):933-7. PubMed ID: 16917913 [Abstract] [Full Text] [Related]
33. [Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome]. Kalashnikova LA, Dobrynina LA, Patrusheva NL, Kovalenko TF, Patrushev LI, Aleksandrova EN, Berkovskiĭ AL, Sergeeva EV, Nasonov EL. Ter Arkh; 2005 Dec 01; 77(10):49-53. PubMed ID: 16320685 [Abstract] [Full Text] [Related]
34. The prevalence of methylenetetrahydrofolate reductase 677 C-T, factor V 1691 G-A, and prothrombin 20210 G-A mutations in healthy populations in Setif, Algeria. Bourouba R, Houcher B, Djabi F, Egin Y, Akar N. Clin Appl Thromb Hemost; 2009 Oct 01; 15(5):529-34. PubMed ID: 18840629 [Abstract] [Full Text] [Related]
36. [Risk of thrombophilia in carriers of thrombophilic genetic factors in unsuccessful assisted reproduction]. Ivanov P, Komsa-Penkova R, Kovacheva K, Konova E, Todorova K, Simeonova M, Ivanov I, Stoĭkov S, Popov I, Tanchev S, Bozhinova S. Akush Ginekol (Sofiia); 2007 Oct 01; 46(6):3-8. PubMed ID: 17974163 [Abstract] [Full Text] [Related]
38. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden. Rahimi Z, Vaisi-Raygani A, Nagel RL, Muniz A. J Thromb Thrombolysis; 2008 Jun 01; 25(3):288-92. PubMed ID: 17619828 [Abstract] [Full Text] [Related]
39. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature. Lenicek Krleza J, Jakovljevic G, Bronic A, Coen Herak D, Bonevski A, Stepan-Giljevic J, Roic G. Pathophysiol Haemost Thromb; 2010 Jun 01; 37(1):24-9. PubMed ID: 20664190 [Abstract] [Full Text] [Related]
40. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis. Ben Salem-Berrabah O, Fekih-Mrissa N, N'siri B, Ben Hamida A, Benammar-Elgaaied A, Gritli N, Mrissa R. J Clin Neurosci; 2012 Sep 01; 19(9):1326-7. PubMed ID: 22721898 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]